Lurie Cancer Center - NUCATS Joint Translational Bridge Award Recipients
The Lurie Cancer Center is pleased to announce the first recipients of the Lurie Cancer Center-NUCATS Joint Translational Bridge Program award, established to advance translational research studies focusing on biological pathways that are dysregulated in both neoplastic and non-neoplastic diseases.
The Lurie Cancer Center-NUCATS joint award will support a Postdoctoral Fellow conducting novel laboratory research under the mentorship of a basic scientist, an oncologist, and a clinician with expertise in a non-neoplastic disease. The postdoctoral fellow supported by this award will, in effect, serve as the fulcrum of a team effort to design and conduct translational research that can impact cancer and at least one other disease.
Please join us in congratulating Jaehyuk Choi, MD, PhD, who was selected as the recipient of the inaugural award for his proposal “Elucidation of targetable signaling pathways shared by cutaneous T- cell lymphoma and the lymphocytic variant of hypereosinophilic syndrome.” In collaboration with medical oncologist Barbara Pro, MD, a specialist in T-Cell lymphomas, Bruce Bochner, MD, an allergist with special expertise in hypereosinophilic syndromes, and postdoctoral fellow, Joonhee Park, PhD, Dr. Choi will follow up on previous work that identified mutations in signaling pathways that promote harmful levels of Th2 cytokine production in each of the diseases. The long-term goal is to determine whether Th2 cytokine production can be reduced by targeting these signaling pathways with therapeutic agents.